ITC Limited, an Indian FMCG conglomerate, continues its long term association with VLife Sciences for consulting research services in the area of novel product design using VLife's proprietary technology platform.

About ITC Limited:
ITC Ltd., a diversified multi-business conglomerate with a market capitalisation of US $ 45 billion and a turnover of over US $ 7 billion, with a diversified portfolio of businesses spanning Fast Moving Consumer Goods, Paper & Packaging, Hotels, Agri Business and Information Technology. Currently the ITC group employs more than 31,000 people in its manufacturing facilities, offices and hotels at more than 60 locations across India.

About VLife:
VLife Sciences Technologies, a divison of NovaLead Pharma Pvt. Ltd., Pune is a leading provider of licensed software and research solutions for research projects in a variety of sectors including genotoxicity predictions . The software offers numerous unique and specialized features for applications in computer aided molecular discovery, bioinformatics, biotechnology and chemoinformatics. Technologies developed by VLife are unique, novel and offer advantages in terms of speed and accuracy thus leading to improved outcome from research projects. VLife offers the VLifeMDS® suite for a comprehensive approach to computer aided drug design and the QSARpro® suite for advanced quantitative structure activity relationships analysis leading to new molecule design.
VLife's ViTAL® for predicting genotoxic potential of impurities and degradation products associated with drug substance or API.

For more details please visit: www.vlifesciences.com or contact us at info@vlifesciences.com